Synairgen (LON:SNG) Shares Down 0.2% – Here’s What Happened

Synairgen plc (LON:SNG)’s share price was down 0.2% on Friday . The stock traded as low as GBX 4.31 ($0.05) and last traded at GBX 4.39 ($0.06). Approximately 26,786 shares were traded during mid-day trading, a decline of 92% from the average daily volume of 316,815 shares. The stock had previously closed at GBX 4.40 ($0.06).

Synairgen Price Performance

The firm has a 50 day moving average of GBX 4.47 and a two-hundred day moving average of GBX 4.54. The company has a market cap of £8.84 million, a PE ratio of -146.33 and a beta of -2.23. The company has a current ratio of 6.77, a quick ratio of 6.35 and a debt-to-equity ratio of 0.09.

Synairgen Company Profile

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.